| __timestamp | Bristol-Myers Squibb Company | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 580006000 |
| Thursday, January 1, 2015 | 12651000000 | 676585000 |
| Friday, January 1, 2016 | 14481000000 | 778966000 |
| Sunday, January 1, 2017 | 14710000000 | 671251000 |
| Monday, January 1, 2018 | 16014000000 | 463508000 |
| Tuesday, January 1, 2019 | 18067000000 | 445724000 |
| Wednesday, January 1, 2020 | 30745000000 | 399725000 |
| Friday, January 1, 2021 | 36445000000 | 296656000 |
| Saturday, January 1, 2022 | 36022000000 | 293122000 |
| Sunday, January 1, 2023 | 34313000000 | 268323000 |
| Monday, January 1, 2024 | 36351000000 | 304979000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding financial health is crucial. This analysis compares the gross profit trends of Bristol-Myers Squibb Company and Taro Pharmaceutical Industries Ltd. from 2014 to 2023. Bristol-Myers Squibb, a titan in the industry, showcased a remarkable growth trajectory, with gross profits peaking in 2021 at approximately 36 billion USD, a threefold increase from 2014. In contrast, Taro Pharmaceutical, a smaller player, experienced a decline, with profits dropping by over 50% from their 2016 peak. This stark contrast highlights Bristol-Myers Squibb's robust market strategies and adaptability, while Taro faces challenges in maintaining its financial momentum. The data for 2024 remains incomplete, leaving room for speculation on future trends. As the pharmaceutical landscape continues to shift, these insights offer a glimpse into the financial dynamics shaping the industry.
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Taro Pharmaceutical Industries Ltd. and MiMedx Group, Inc.